prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |review

Click for larger picture

Now the trends for esophageal cancer become clearer when divided by cell type. Once an uncommon tumor, esophageal adenocarcinoma in white men has risen more rapidly (about 8 to 9% per year) than any other cancer, shooting past the rate for esophageal squamous cell cancer, which is on the decline. The racial disparities are also striking, with adenocarcinoma being 5 to 6 times more common in the white compared to the black population, while the opposite occurs for squamous cell cancer. In collaboration with groups at Columbia, Yale and the University of Washington, our study of esophageal adenocarcinoma revealed two major risk factors that are increasing in prevalence in the population – gastroesophageal reflux disease and obesity. Obesity in turn promotes reflux, but it also appears to act at a later stage in the transition from Barrett’s esophagus to cancer. In addition, we found an inverse association with Helicobacter pylori infection, which has declined along with the incidence of gastric cancer in the general population. A protective effect of H. pylori would be consistent with the intriguing hypothesis of Martin Blaser that H. pylori, by colonizing the gastric mucosa, may actually block the secretion and reflux of gastric acid.